Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)








2020 CDC U.S. TB Elimination Champions						Print
																Related Pages
										**Collaborating with public health partners, health care providers, and community organizations**
Return to TB Elimination ChampionsOpen All Close AllJeannette Aldous, MD – Clinical Director of Infectious Disease, San Ysidro Health CAaldousJeannette Aldous, MD
Dr. Aldous is dedicated to the elimination of TB.  Working with the San Diego TB program to improve coordination, she has helped ensure that public health TB prevention efforts are appropriately modified for implementation in the primary healthcare setting, where individuals and families are tested and treated for LTBI to prevent TB in her community of San Ysidro, a community-at-risk.Breathe Easy South Texas (B.E.S.T) Project – San Antonio, TexasB.E.S.T. PicSan Antonio Metro Health:  Tommy Camden, Norma Santos, Yvonne Reza, Audrey Avila, Norma Wagoner, Adrianna Estrada, Leticia Pinzon, Carol Staton, Anita Kurian, Rob Pruett  UT Tyler/Heartland National TB Center: Lisa Armitige, MD , Texas Center for Infectious Disease:  Sergio Orozco, MD
Not pictured: Centro Med: Delma Ochoa, Texas DSHS Region 8:  Lillian Ringsdorf, MD; Gale Morrow, Yolanda Cantu, San Antonio AIDS Foundation: Cynthia Nelson,  UTHealth:  Barbara Taylor, MD
Breathe Easy South Texas (B.E.S.T.) is a collaboration of governmental and private agencies specifically dedicated to performing targeted testing and treatment of latent TB infection. The program has been successful in extending the capacity and function of local public health agencies to address critical gaps in TB prevention.  Recent studies and analysis of operational data as well as a Costs and Savings Report have demonstrated there have been positive economic, social, and health benefit returns.CDC’s Division of Tuberculosis Elimination Laboratory Branch and Surveillance, Epidemiology, and Outbreak, Investigations Branch/Molecular Epidemiology ActivityCDC-TB-BranchPhoto on Left
Lauren Cowan, Monica Youngblood, Cortney Stafford, Beverly Metchock, David Sikes, Matthew Ezewudo, Atanaska Marinova-Petkova Front row: Stephanie Johnston, James Posey, and Scott Burns
Not pictured: Scott Chancey, Tracy Dalton Kate Klein, Angela Starks
Photo on Right
Back Row: Yuri Springer, Clint McDaniel, Benjamin Silk, Steve Kammerer
Front Row: Julie Self, Sarah Talarico, Kala Raz, Nancy Chow
Staff in the Division of Tuberculosis Elimination are dedicated to strengthening national tuberculosis surveillance through the optimization and implementation of whole genome sequencing (WGS). Implementation of WGS at the National Tuberculosis Molecular Surveillance Center strengthens national TB surveillance for detection of outbreaks and drug resistance (e.g., *rpoB* alerts).  WGS examines over 90% of the genome and can improve accuracy of outbreak detection systems. This additional information can aid public health authorities to conduct more targeted interventions.Bruce Chandler, MD, MPH – Medical Officer with the Division of Public Health, State of Alaska and Public Health Division, Municipality of AnchorageB. ChandlerFront Row (L-R):  Michael Fritz, Lisa Sauder, Heidi Hurliman, Cecile Manalo, S. Rachel Gallegos, Leigh Boone, Debra Blanchard, Yolanda Adams, Jessica Ellis, Jordan Kamer, Sam McElwee
Back Row (L-R):  Robert Orallo, Jacob Lim, Scott Lingle, Numia Failagi, Drew Shannon, Bruce Chandler
Dr. Bruce Chandler is a passionate champion in the fight to eliminate TB from Alaska.  He is a leader in the Alaska TB Program. Dr. Chandler’s work continues to raise awareness of the ongoing challenges of TB prevention and control in Alaska.  He is an excellent teacher, a compassionate healthcare provider, and an approachable and generous consultant.  His deep understanding of the history and current challenges of TB in Alaska are a tremendous resource.DeKalb County, GA Board of Health Refugee and Tuberculosis ProgramDeKalb County, GA Board of Health Refugee and Tuberculosis Program1st row – Dr. A. Oladele, Dr. S. Bedane, Karen Moore, Pingala Sharma, Sharon Rodriguez,  Zaenab Amedi,
                 and Laverna Clarke
2nd row – Juanita Martin, Natalie Hill, Saida Nur, Rezwana Uddin, Naw Taw, Mielat Solomon, Rebecca Ajibola
3rd row – Farhad Jameel, Carolyn Baker, Maureen Wakhsi, Jade Mitchell, Tony Holmes, Deo Tamang,
                 Negasi Endreas, and Ahmed Mohamed
The Dekalb County Board of Health Refugee and Tuberculosis Program implements culturally appropriate and innovative strategies grounded in best practices that address the unique and diverse TB epidemics in their community to end TB.  Foreign-born individuals have the highest incidence rate of TB in DeKalb County, accounting for 77% of all cases in 2017. Using culturally appropriate and innovative TB prevention and treatment strategies has resulted in optimal case detection and management of TB in their community.Genesee and Orleans County Health Departments, New Yorknurse-tb-photoBackrow: Kerry Miller, Kerry Ohlson, Carla Wahls, Melissa Pless
Frontrow: Mary Ellen Messmer, Deborah Restivo, Doris Delano, Kayla Shuknecht
Genesee and Orleans County Health Departments partner to test and treat TB disease and latent TB infection in migrant farmworker camps. Working together with a local federally funded qualified health center, they have adapted how they provide directly observed therapy to better match the schedules of their clients. This partnership allows them to provide TB screening and treatment for TB disease and latent TB infection to over 70 migrant farmworker camps in both counties.Hope Clinic LTBI Team - Hope Clinic & Houston Health Department Bureau of TB, Texashope clinicHanan Noori, MA Hope Clinic; Maria Galvis, CDC PHA assigned to Houston Health Dept.; Tonia Ellison, LVN Houston Health Dept.; Barbarah Martinez RN, BSN  Hope Clinic; Kara Green MSN, APRN, FNP-BC Hope Clinic; Nguyen Tran, MA Hope Clinic
The Hope Clinic and Houston Health Department staff collaborate to provide latent TB infection (LTBI) treatment in high-risk communities in Houston, TX. The Hope Clinic LTBI team are dedicated to educating and delivering the 12-dose regimen to treat LTBI through directly observed therapy to their patients onsite resulting in a completion rate above 80%.  The Hope Clinic staff says “it’s time to test and treat latent TB infection” and is putting those words into action by continuing their patient enrollment and partnership with the Houston Health Department.Jefferson County Department of Health, AlabamaJeffersonCountyCharles Esther Kellum, Linda Hannon, Beverly Foy, Sherai Robinson, Angela Ragan, Rominka Ellis, Defellus Dumas, Rachel Hobgood, and Dr. A. Edward Khan.
The staff of Jefferson County Department of Health’s TB Program are working to end TB through screening, treatment, contact investigation, and community education. JCDH’s TB staff has decreased the spread of TB in the community by offering treatment to all patients with latent TB infection, providing directly observed therapy for patients with TB disease, offering testing to high risk populations, and increasing awareness of TB (symptoms and treatment) by attending community events.Karen Landers, MD F.A.A.P – District Health Officer, Medical Consultant for State TB Program, Alabama Department of Public HealthTB program staffRodriko Sankey, Karen Landers, MD, Pamela Barrett
Dr. Karen Landers is a skilled physician, public health leader, and passionate advocate for patients and communities who works tirelessly as a TB Elimination Champion! Dr. Landers fought for state funding for a young patient’s specialized treatment/surgery in another state, saving her life. She and her team implemented a program to stop INH-resistant TB transmission and prevent new disease in a vulnerable community. She remains 100% committed to training public health workers to “Stop TB”.Julie Low, MD– TB Controller, Orange County Health Care Agency, CaliforniaPhoto LowLeft to right: Faye Truax, Setie Asfaha, Julie Low, Tessa Mochizuki
Dr. Low is a TB Elimination Champion, promoting TB awareness and practical strategies to test and treat latent TB infection in Orange County, CA. As the TB controller of a high-incidence county in California, Dr. Low works tirelessly to engage local healthcare providers and educate them on latent TB infection testing and treatment. In partnership with TB Free California, she has helped established quality improvement projects focused on latent TB infection treatment at two clinic sites in Orange County.Michigan Department of Health and Human Services, Bureau of LaboratoriesTeamGenotyping_TBDayDaniel Gard, Rebecca Kramer, Kimberly McCullor, Laurel Vibber, and Kourtney Wells
Michigan Department of Health and Human Services (MIDHHS) recognizes “It’s Time” to strengthen national tuberculosis surveillance through implementation of universal whole genome sequencing for isolates of *Mycobacterium tuberculosis.* The implementation of universal whole genome sequencing at MIDHHS as the National Tuberculosis Molecular Surveillance Center strengthens national TB surveillance for detection of outbreaks and drug resistance.  MDHHS has extensive experience with genotyping of *M. tuberculosis* and currently performs testing on ~9,000 isolates per year.Marisa Moore, M.D., MPH – U.S public Health Service, Tuberculosis Control and Refugee Health County of San Diego Health & Human Services Agency, CaliforniaMarisa Moore, M.D., MPHMarisa Moore, M.D., MPH
For over 20 years Dr. Marisa Moore has worked to improve TB care and prevention, through her epidemiologic research and participation in the California TB Elimination Task Force.  By improving surveillance systems and processes, increasing partnerships with primary care clinics serving communities at risk, contributing expertise to state TB elimination efforts and epidemiologic study design and implementation, she has worked to ensure quality care for persons living in San Diego.Eric Morgan, BS, MPH, DIPM - Statewide TB Manager/Prison Liaison, Coordinator for Minority Health, Alabama Department of Health, Division of TB ControlEricMorganEric Morgan
Eric Morgan was an advocate for TB elimination in correctional settings.  His work as Alabama’s Coordinator for Minority Health and Prison Liaison will long be remembered. Eric Morgan gained trust, built rapport, and established strong communications with Alabama’s prison facilities. He conducted chart audits and maintained a database to monitor treatment completion as part of the community re-entry program. As a result of Eric’s interventions, many inmates reported to Alabama’s DOH following their release from prison.Saint Louis County Department of Public Health Chest Clinic, MissouriChest_Clinic_image_STLCoFrom left to right: Anntionette Ford, MA; Jenelle Leighton, RN, BSN; Elizabeth Jones, RN, BS; Jennifer Hurd, MPH; Jennifer Philippe, MA; James Imperial, RN, BSN; Barbara Kuntz, RN. Not pictured: Thomas C. Bailey, MD; Latania Wilson, MA
The Chest Clinic provides expertise to our community, evaluates and treats TB disease and latent TB infection, and trains future healthcare providers to “think TB”  using hands-on experiences. The Chest Clinic’s healthcare community uses the Chest Clinic to provide guidance and specialized care for their residents. In partnership with a local university, the clinic helps our future physicians to understand their role in controlling and preventing TB disease.Jacek Skarbinski - Physician, Department of Infectious Diseases, Kaiser Permanente Oakland/Richmond, CaliforniaJacek Skarbinski, MDJacek Skarbinski, MD
Dr. Skarbinski is a passionate TB Elimination Champion, dedicated to preventing TB cases and promoting successful practices within Kaiser Permanente and throughout California. Dr. Skarbinski studies latent TB treatment practices within Kaiser, educates colleagues on testing and treating LTBI, and is working to establish a regional center of excellence for LTBI. In partnership with California Department of Public Health, Dr. Skarbinski is also piloting a quality measure related to LTBI testing and treatment.Dr. Chris Spitters - Interim Health Officer, Snohomish Health District, WashingtonChris Spitters, MDChris Spitters, MD
Dr. Chris Spitters has worked in TB for 25 years, and is a trusted TB provider exceptionally dedicated to testing and treating latent TB infection (LTBI). He manages approximately 200 LTBI cases per year, in addition to managing and consulting on TB cases around Washington state.  Dr. Spitters is a kind, calming, and down-to-earth TB Elimination Champion who uniquely shares his clinical decision-making process with colleagues and encourages a patient-centered approach to TB management.Wadsworth Center, New York State Department of Health (NYSDOH)Wadsworth Center, New York State Department of Health (NYSDOH)Justine Edwards, Vincent Escuyer, Alexandra Fiero, Tanya Halse, Michelle Isabelle, Donna Kohlerschmidt, Pascal Lapierre, Melissa Leisner, Helen Ling, Kimberly Musser, Erasmus Schneider, Joseph Shea, Matthew Shudt, Jill Taylor (not pictured), Colleen Walsh, and Susan Wolfe
Wadsworth Center (NYSDOH) recognizes “It’s Time” to strengthen clinical testing for detection of drug resistance through the implementation of whole genome sequencing for isolates of *Mycobacterium tuberculosis.* In New York State, the implementation of whole genome sequencing at NYSDOH for clinical testing of *Mycobacterium tuberculosis* has improved testing algorithms and the turnaround time of drug susceptibility test results.
							
					
							Last Reviewed:  March 14, 2019						Source: 	Division of Tuberculosis Elimination
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue